Irisin induces angiogenesis in human umbilical vein endothelial cells in vitro and in zebrafish embryos in vivo via activation of the ERK signaling pathway

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Wu, Fei ^a   Song, Haibo ^a   Zhang, Yuan ^a   Zhang, Yuzhu ^a   Mu, Qian ^a   Jiang, Miao ^a   Wang, Fang ^a   Zhang, Wen ^a   Li, Liang ^a   Li, Huanjie ^b   Wang, Yunshan ^b   Zhang, Mingxiang ^c   Li, Shiwu ^d   Yang, Lijun ^d   Meng, Yan ^a   Tang, Dongqi ^a  

^a THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; IRISIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 9; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GELATINASE B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ZEBRA FISH; ANIMAL; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; FIBRONECTINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; UP-REGULATION; ZEBRAFISH;

EID: 84942084767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134662     Document Type: Article

References (40)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. nature. 2000; 407(6801):249-57. PMID: 11001068
2. Ellis LM, Liu W, Ahmad SA, Fan F, Jung YD, Shaheen RM, et al., editors. Overview of angiogenesis: biologic implications for antiangiogenic therapy. Seminars in oncology; 2001: Elsevier.
3. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005; 438(7070):932-6. PMID: 16355210
4. Ebrahimian TG, Tamarat R, Clergue M, Duriez M, Levy BI, Silvestre JS. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arteriosclerosis, thrombosis, and vascular biology. 2005 Jan; 25(1):65-70. PMID: 15528473. doi: 10.1161/01.ATV.0000149377.90852. d8
5. Albini A, Indraccolo S, Noonan DM, Pfeffer U. Functional genomics of endothelial cells treated with anti-Angiogenic or angiopreventive drugs. Clinical & experimental metastasis. 2010 Aug; 27(6):419-39. PMID: 20383568. doi: 10.1007/s10585-010-9312-5
6. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-[agr]-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. doi: 10.1038/nature10777 PMID: 22237023
7. Wu J, Boström P, Sparks Lauren M, Ye L, Choi Jang H, Giang A-H, et al. Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human. Cell. 2012 7/20/; 150(2):366-76. http://dx.doi. org/10.1016/j.cell.2012.05.016. doi: 10.1016/j.cell.2012.05.016 PMID: 22796012
8. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-Activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014; 63(2):514-25. doi: 10.2337/db13-1106 PMID: 24150604
9. Choi Y-K, Kim M-K, Bae KH, Seo H, Jeong J-Y, Lee W-K, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes research and clinical practice. 2013; 100(1):96-101. doi: 10.1016/j.diabres.2013. 01.007 PMID: 23369227
10. Liu J-J, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 2013; 27(4):365-9. doi: 10.1016/j. jdiacomp.2013.03.002 PMID: 23619195
11. Zhang M, Chen P, Chen S, Sun Q, Zeng Q, Chen J, et al. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study. European review for medical and pharmacological sciences. 2014; 18(11):1567-72. PMID: 24943964
12. Aronis K, Moreno M, Polyzos S, Moreno-Navarrete J, Ricart W, Delgado E, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. International Journal of Obesity. 2013.
13. Moon H-S, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013; 62(8):1131-6. doi: 10.1016/j.metabol.2013.04.007 PMID: 23664146
14. Colaianni G, Cuscito C, Mongelli T, Oranger A, Mori G, Brunetti G, et al. Irisin enhances osteoblast differentiation in vitro. Int J Endocrinol. 2014; 2014:902186. PMID: 24723951. Pubmed Central PMCID: PMC3960733. doi: 10.1155/2014/902186
15. Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, et al. Irisin Promotes Human Umbilical Vein Endothelial Cell Proliferation through the ERK Signaling Pathway and Partly Suppresses High Glucose-Induced Apoptosis. PLoS One. 2014; 9(10):e110273. PMID: 25338001. doi: 10.1371/journal.pone. 0110273
16. Li SW, Sun Y, Donelan W, Yu H, Scian J, Tang D, et al. Expression, purification, and characterization of recombinant human pancreatic duodenal homeobox-1 protein in Pichia pastoris. Protein expression and purification. 2010 Aug; 72(2):157-61. PMID: 20381624. Pubmed Central PMCID: PMC3408096. 10.1016/j.pep.2010.04.004. doi: 10.1016/j.pep.2010.04.004
17. Lu J, Li P, Yu D. 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Research. 2010; 70(8 Supplement):5760.
18. Pourgholami MH, Khachigian LM, Fahmy RG, Badar S, Wang L, Chu SWL, et al. Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis. Biochemical and biophysical research communications. 2010; 397(4):729-34. doi: 10.1016/j.bbrc.2010.06.019 PMID: 20537982
19. Deryugina E, Quigley J. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006 2006/03/01; 25(1):9-34. doi: 10.1007/s10555-006-7886-9 PMID: 16680569
20. Herron G, Banda M, Clark E, Gavrilovic J, Werb Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. Journal of Biological Chemistry. 1986; 261(6):2814-8. PMID: 3005266
21. Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000 Apr 15; 60(8):2178-89. PMID: 10786682.
22. Tal TL, McCollum CW, Harris PS, Olin J, Kleinstreuer N, Wood CE, et al. Immediate and long-term consequences of vascular toxicity during zebrafish development. Reproductive Toxicology. 2014 9//; 48 (0):51-61. http://dx.doi.org/10.1016/j.reprotox.2014.05.014.
23. Kessenbrock K, Plaks V, Werb Z. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell. 2010 4/2/; 141(1):52-67. http://dx.doi.org/10.1016/j.cell.2010.03.015. doi: 10.1016/j.cell. 2010.03.015 PMID: 20371345
24. Nagase H, Woessner JF. Matrix Metalloproteinases. Journal of Biological Chemistry. 1999; 274 (31):21491-4. doi: 10.1074/jbc.274.31.21491 PMID: 10419448
25. Hunter J. A treatise on the blood, inflammation, and gun-shot wounds. 1794. Clinical orthopaedics and related research. 2007 May; 458:27-34. PMID: 17473595. doi: 10.1097/BLO.0b013e31803dd01c
26. Albrecht-Schgoer K, Schgoer W, Holfeld J, Theurl M, Wiedemann D, Steger C, et al. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells. Circulation. 2012 Nov 20; 126 (21):2491-501. PMID: 23081990. Pubmed Central PMCID: PMC3839617. doi: 10.1161/circulationaha. 111.076950
27. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414 (6865):813-20. PMID: 11742414
28. Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation. 1998 May 5; 97 (17):1695-701. PMID: 9591763.
29. Hashemi MS, Ghaedi K, Salamian A, Karbalaie K, Emadi-Baygi M, Tanhaei S, et al. Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience. 2013 Feb 12; 231:296-304. PMID: 23219938. doi: 10.1016/j.neuroscience.2012.11.041
30. Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA. Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. International journal of cancer Journal international du cancer. 2014 Aug 14. PMID: 25124080. doi: 10.1002/ijc.29142
31. Singhal V, Lawson EA, Ackerman KE, Fazeli PK, Clarke H, Lee H, et al. Irisin levels are lower in young amenorrheic athletes compared with eumenorrheic athletes and non-Athletes and are associated with bone density and strength estimates. PLoS One. 2014; 9(6):e100218. PMID: 24926783. Pubmed Central PMCID: PMC4057451. doi: 10.1371/journal.pone.0100218
32. Kim BS, Park JY, Kang HJ, Kim HJ, Lee J. Fucoidan/FGF-2 induces angiogenesis through JNK-And p38-mediated activation of AKT/MMP-2 signalling. Biochem Biophys Res Commun. 2014 Aug 8; 450 (4):1333-8. PMID: 25003321. doi: 10.1016/j.bbrc.2014.06.137
33. Jin YJ, Park I, Hong IK, Byun HJ, Choi J, Kim YM, et al. Fibronectin and vitronectin induce AP-1-mediated matrix metalloproteinase-9 expression through integrin alpha(5)beta(1)/alpha(v)beta(3)-dependent Akt, ERK and JNK signaling pathways in human umbilical vein endothelial cells. Cellular signalling. 2011 Jan; 23(1):125-34. PMID: 20816750. doi: 10.1016/j.cellsig.2010.08.012
34. Lai C-F, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, et al. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. Journal of Biological Chemistry. 2001; 276(17):14443-50. PMID: 11278600
35. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et biophysica acta. 2010 Apr; 1802(4):396-405. PMID: 20079433. doi: 10.1016/j.bbadis.2009.12.009
36. Park YS, Hwang S, Jin YM, Yu Y, Jung SA, Jung SC, et al. CCN1 secreted by tonsil-derived mesenchymal stem cells promotes endothelial cell angiogenesis via integrin alphav beta3 and AMPK. Journal of cellular physiology. 2015 Jan; 230(1):140-9. PMID: 24909560. doi: 10.1002/jcp.24690
37. Iacobazzi D, Garaeva I, Albertario A, Cherif M, Angelini GD, Caputo M, et al. Protein Phosphatase 1 Beta is Modulated by Chronic Hypoxia and Involved in the Angiogenic Endothelial Cell Migration. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2015; 36(1):384-94. PMID: 25967976. doi: 10.1159/000430257
38. Dong F, Zhou X, Li C, Yan S, Deng X, Cao Z, et al. Dihydroartemisinin targets VEGFR2 via the NF-kappaB pathway in endothelial cells to inhibit angiogenesis. Cancer biology & therapy. 2014; 15(11):1479-88. PMID: 25482945. doi: 10.4161/15384047.2014.955728
39. Zhang C, Gao F, Teng F, Zhang M. Fas/FasL Complex Promotes Proliferation and Migration of Brain Endothelial Cells Via FADD-FLIP-TRAF-NF-kappaB Pathway. Cell biochemistry and biophysics. 2014 Nov 27. PMID: 25427888. doi: 10.1007/s12013-014-0351-4
40. Biscetti F, Straface G, Pitocco D, Zaccardi F, Ghirlanda G, Flex A. Peroxisome proliferator-Activated receptors and angiogenesis. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2009 Dec; 19 (11):751-9. PMID: 19628379. doi: 10.1016/j.numecd.2009.04.011